Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s disease

2 Sept 2021

Abstract excerpt

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease. However, it is unclear whether microbiota and metabolites have demonstrated changes at early PD due to the difficulties in diagnosis and identification of early PD in clinical practice. In a previous study, we generated A53T transgenic monkeys with early Parkinson's symptoms, including anxiety and cognitive impairment. Here we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Gut microbiota and health
Share to Nutrition and Health in Aging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34475403
DOI: 10.1038/s41522-021-00242-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s diseasePMID 34475403Read ↗

Functional Metagenomic Analysis Reveals Early Gut Microbiota Alterations in Alpha-Synuclein Transgenic Mice: Insights into Parkinson’s Disease ProgressionSemantic proximity Read ↗

α-synuclein overexpression and the microbiome shape the gut and brain metabolome in miceSemantic proximity Read ↗

α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in MiceSemantic proximity Read ↗

Alterations of gut microbiota and metabolome with Parkinson's diseaseSemantic proximity Read ↗

A review of studies on gut microbiota and levodopa metabolismSemantic proximity Read ↗

Analysis of Gut Microbiota in Patients with Parkinson’s DiseaseSemantic proximity Read ↗

Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson diseaseSemantic proximity Read ↗

Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain AxisSemantic proximity Read ↗

Gut microbiota, 1013 new pieces in the Parkinson's disease puzzleSemantic proximity Read ↗

Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical featuresSemantic proximity Read ↗

Hydroxypropyl-β-cyclodextrin-complexed resveratrol protects A53T transgenic Parkinson’s disease mice via modulating signaling pathways of the microbiota-gut-brain axisSemantic proximity Read ↗

Altered gut microbiome and metabolism in synucleinopathies and iRBD using multimodal differential abundance analysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.